Genome Engineering: From Mechanisms to Therapies

The goal of this Keystone Symposia conference is to bring together those developing and studying genome engineering tools with groups who are applying them to build new disease models, identify disease mechanisms and drug targets, and develop cell-based therapeutics and genetic medicines. In addition to covering engineering of human and animal cells, this conference will also highlight the emerging field of genome engineering to identify new anti-microbial and anti-viral drugs and applications toward next-generation antibiotics.

Scientists Having Hard Time Keeping Track Of Patients Who Have Undergone Gene-Editing Treatments In China

According to the Wall Street Journal, a number of cancer patients in China underwent gene modification with the gene-editing tool, CRISPR-Cas9, but some scientists who administered the trial have neglected to keep track of patients who underwent gene-editing treatment.

The Hope and Challenge of Synthetic Biology

Mankind’s newfound ability to edit germline codes will soon be widely available. We will also be able to extend the palette of naturally available amino acids for molecular assembly. The US needs a policy framework that defines and addresses the five key decisions that will determine whether we can leverage the benefits and simultaneously defend against attacks.